ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 399

Enthesitis in Juvenile Idiopathic Arthritis (JIA)

Dax G. Rumsey1, Jaime Guzman2, Alan Rosenberg3, Adam Huber4, Rosie Scuccimarri5, Dean Eurich6 and Research in Arthritis in Canadian Children Emphasizing Outcomes (ReACCh-Out) Investigators, 1Paediatrics, University of Alberta, Edmonton, AB, Canada, 2Rheumatology, BC Children's Hospital, Vancouver, BC, Canada, 3Pediatrics, Pediatrics, Saskatoon, SK, Canada, 4IWK Health Centre, Halifax, NS, Canada, 5Division of Pediatric Rheumatology, Montreal Children's Hospital / McGill University Health Centre, Montreal, QC, Canada, 6University of Alberta, Edmonton, AB, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Enthesitis and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster I: Juvenile Idiopathic Arthritis, Uveitis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Enthesitis in Juvenile Idiopathic Arthritis (JIA)

Background/Purpose: The characteristics of enthesitis,  a feature  in some children with juvenile idiopathic arthritis (JIA),  t has not been well described in large prospective inception cohorts. We used data from a Canadian cohort to describe the characteristics of patients with enthesitis, the sites most commonly affected, and the temporal changes in the number of sites of enthesitis, relative to changes in active joint counts.

Methods: Children newly diagnosed with JIA at 16 Canadian centers from 2005 to 2010 were followed in the ReACCh-Out cohort for up to 5 years. For this analysis, all patients with >1 visit (n=1406) were included.  The presence and location of enthesial tenderness on examination were recorded by pediatric rheumatologists in all children present at 0, 6, 12, 18, 24, 36, 48 and 60 months after enrolment.  For this study, a child was said to have enthesitis if enthesial tenderness was present on >1 occasion and/or at >1 body site.  The characteristics of patients with an without enthesitis were compared using univariate logistic regression on each characteristic.  The number of tender enthesial sites was analyzed over time and compared to the number of active joint counts using linear mixed models for longitudinal data.  

Results: A total of 219 patients (16% of the cohort) fulfilled our criteria for enthesitis; 8% fulfilled criteria at enrolment and 15% fulfilled criteria within 2 years.  The most frequent sites of involvement were the calcaneal plantar insertion (39%), Achilles insertion (31%), and tibial tuberosity (30%).  The characteristics of children with and without enthesitis are presented in Table 1.  Children with enthesitis were older, more often male and 141 (64.4%) were categorized as enthesitis related arthritis; 57.1% had polyarticular involvement and 30% had sacroiliac involvement at some point during follow-up. The mean number of tender enthesial sites decreased dramatically over the follow-up period, roughly in parallel with the number of active joints (see Figure 1, p=0.16 for whole group).  A mixed linear model analysis showed no significant difference in active joint counts over time in children with or without enthesitis (p=0.73).

Conclusion: The number of patients with enthesitis and their characteristics were generally as expected, except that over half the patients had polyarticular involvement.  The number of tender enthesial sites and active joints decreased similarly over time in the enthesitis group, and the active joint counts decreased similarly over time in children with and without enthesitis. Table 1: Characteristics of Patients With Versus Without Enthesitis

Characteristic

Patients with Enthesitis

Patients without Enthesitis

OR (95% CI)

Number with Enthesitis

219 (15.6%)

1187 (84.4%)

 

Age of onset of JIA (Mean)

10.7 yrs (SD 3.2 yrs)

7.5 years (SD 4.6 yrs)

1.21 (1.16 Ð 1.26)

Male Sex

124 (56.6%)

365 (30.8%)

2.89 (2.15 Ð 3.88)

ANA Positive*

51 (23.3%)

563 (47.4%)

0.33 (0.24 Ð 0.47)

HLA-B27 Present**

70 (32.0%)

75 (6.3%)

4.58 (3.09 Ð 6.81)

JIA Subtype (Initial)

 

 

 

-ERA

141 (64.4%)

61 (5.1%)

Reference

-Oligoarticular

13 (5.9%)

546 (46%)

0.010 (0.006 Ð 0.02)

-Polyarticular RF Ðve

17 (7.8%)

256 (21.6%)

0.029 (0.02 Ð 0.05)

-Polyarticular RF +ve

4 (1.8%)

53 (4.5%)

0.033 (0.01 Ð 0.09)

-Systemic

0 (0%)

86 (7.25%)

Cannot compute

-Psoriatic

5 (2.3%)

83 (7.0%)

0.026 (0.01 Ð 0.067)

-Unclassified

39 (17.8%)

102 (8.6%)

0.17 (0.1 Ð 0.27)

Uveitis (ever)

21 (9.6%)

198 (16.7%)

0.53 (0.33 Ð 0.85)

Sacroiliitis (ever)

66 (30.1%)

43 (3.6%)

11.5 (7.5 Ð 17.5)

Psoriasis (ever)

57 (26.0%)

273 (23.0%)

1.18 (0.85 Ð 1.64)

Polyarticular involvement (ever)

125 (57.1%)

487 (41.0%)

1.91 (1.43 Ð 2.56)

 

*ANA status unknown in 11.9% of the enthesitis group and 8.4% of the no enthesitis group **HLA-B27 status unknown in 26.5% of the enthesitis group and 56.0% of the no enthesitis group   Figure 1: Mean Number of Tender Enthesial Sites and Active Joints in Children with Enthesitis

Figure1.png


Disclosure: D. G. Rumsey, None; J. Guzman, None; A. Rosenberg, None; A. Huber, None; R. Scuccimarri, None; D. Eurich, None.

To cite this abstract in AMA style:

Rumsey DG, Guzman J, Rosenberg A, Huber A, Scuccimarri R, Eurich D. Enthesitis in Juvenile Idiopathic Arthritis (JIA) [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/enthesitis-in-juvenile-idiopathic-arthritis-jia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enthesitis-in-juvenile-idiopathic-arthritis-jia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology